Phase II study of S-1 plus oxaliplatin 130  mg/m 2 in Japanese patients with advanced gastric cancer

ConclusionResults indicated that SOX130 was feasible in Japanese patients with advanced gastric cancer.
Source: International Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research